EV/EBITDA
-0.86
+0.02+2.27%
Wed, 27 Nov 2024 14:30:00 GMT
Summary:
Context Therapeutics EV/EBITDA is currently -0.86, with a rise of +0.02 (+2.27%) during the most recent trading day. Over the past year, it has dropped by -1.25 (-320.51%). CNTX EV/EBITDA is now -140.19% below its all-time high of 2.14.CNTX EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CNTX EV/EBITDA Performance
| PeriodPeriod | EV/EBITDAEV/EBITDA |
|---|---|
| todaytoday | +2.3% |
| 1 m1 month | +68.5% |
| 3 m3 months | +80.0% |
| 6 m6 months | +86.6% |
| ytdytd | -514.3% |
| 1 y1 year | -320.5% |
| 5 y5 years | - |
CNTX EV/EBITDA High & Low
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1 month | -0.44 | -95.5% | -2.89 | +70.2% |
| 3 m | 3 months | -0.44 | -95.5% | -4.29 | +80.0% |
| 6 m | 6 months | -0.44 | -95.5% | -6.97 | +87.7% |
| 1 y | 1 year | 0.39 | -320.5% | -6.97 | +87.7% |
| 3 y | 3 years | 2.14 | -140.2% | -19.76 | +95.7% |
| 5 y | 5 years | 2.14 | -140.2% | -19.76 | +95.7% |
| alltime | all time | 2.14 | -140.2% | -19.76 | +95.7% |
Context Therapeutics EV/EBITDA History
| Date | Value |
|---|---|
| 2024 | -0.86(+514.3%) |
| 2023 | -0.14(-108.2%) |
| Date | Value |
|---|---|
| 2022 | 1.70(+146.4%) |
| 2021 | 0.69 |
FAQ
- What is Context Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Context Therapeutics?
- What is CNTX EV/EBITDA year-to-date change?
- What is Context Therapeutics EV/EBITDA year-on-year change?
What is Context Therapeutics EV/EBITDA?
The current EV/EBITDA of CNTX is -0.86
What is the all time high EV/EBITDA for Context Therapeutics?
Context Therapeutics all-time high EV/EBITDA is 2.14
What is CNTX EV/EBITDA year-to-date change?
Context Therapeutics EV/EBITDA has changed by -0.72 (-514.29%) since the beginning of the year
What is Context Therapeutics EV/EBITDA year-on-year change?
Over the past year, CNTX EV/EBITDA has changed by -1.25 (-320.51%)